Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Debruyne

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
European Journal of Cancer Care|April 25, 2014
Themes for our journal: 2014-2016P R Debruyne, V E Knott, D Weller
European Journal of Cancer Care|June 19, 2013
A call for rigorous research and transparent study reporting …P R Debruyne, V E Knott, N A Pattison
Journal De Pharmacie De Belgique|May 9, 2014
[(Added) Value of a clinical pharmacist in the oncology department and optimalisation of the applicability of geriatric tools assessing potential inappropriate medication use in geriatric patients (Drug Burden Index and de Beers criteria)]J Van Den Broucke, A Verhaeghe, P R Debruyne, et al.
Mutation Research|August 17, 2001
The role of bile acids in carcinogenesisP R Debruyne, E A Bruyneel, X Li, et al.
European Journal of Cancer Care|February 26, 2015
Integration of geriatric oncology in daily multidisciplinary cancer care: the time is nowM Lycke, L Pottel, T Boterberg, et al.
Oncogene|October 3, 2002
Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathwaysP R Debruyne, E A Bruyneel, I-M Karaguni, et al.
Acta Clinica Belgica|July 25, 2014
Prospective non-interventional multicentre observational trial of first-line anti-cancer treatment in patients with metastatic renal cell cancer in BelgiumN Cornelis, T Vermassen, D Schallier, et al.
ESMO Open|March 22, 2023
Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: a phase II, open-label, multicenter, multicohort studyE Sherman, J L Lee, P R Debruyne, et al.
Clinical & Experimental Metastasis|August 5, 2000
hMSH6 deficiency and inactivation of the alphaE-catenin invasion-suppressor gene in HCT-8 colon cancer cellsS J Vermeulen, P R Debruyne, G Marra, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Cardiovascular toxicities in cancer patients treated with immune checkpoint inhibitors: multicenter study using natural language processing on Belgian hospital dataD Delombaerde, C L Oeste, V Geldhof, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
European Journal of Cancer Care|April 25, 2014
Themes for our journal: 2014-2016P R Debruyne, V E Knott, D Weller
European Journal of Cancer Care|June 19, 2013
A call for rigorous research and transparent study reporting …P R Debruyne, V E Knott, N A Pattison
Journal De Pharmacie De Belgique|May 9, 2014
[(Added) Value of a clinical pharmacist in the oncology department and optimalisation of the applicability of geriatric tools assessing potential inappropriate medication use in geriatric patients (Drug Burden Index and de Beers criteria)]J Van Den Broucke, A Verhaeghe, P R Debruyne, et al.
Mutation Research|August 17, 2001
The role of bile acids in carcinogenesisP R Debruyne, E A Bruyneel, X Li, et al.
European Journal of Cancer Care|February 26, 2015
Integration of geriatric oncology in daily multidisciplinary cancer care: the time is nowM Lycke, L Pottel, T Boterberg, et al.
Oncogene|October 3, 2002
Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathwaysP R Debruyne, E A Bruyneel, I-M Karaguni, et al.
Acta Clinica Belgica|July 25, 2014
Prospective non-interventional multicentre observational trial of first-line anti-cancer treatment in patients with metastatic renal cell cancer in BelgiumN Cornelis, T Vermassen, D Schallier, et al.
ESMO Open|March 22, 2023
Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: a phase II, open-label, multicenter, multicohort studyE Sherman, J L Lee, P R Debruyne, et al.
Clinical & Experimental Metastasis|August 5, 2000
hMSH6 deficiency and inactivation of the alphaE-catenin invasion-suppressor gene in HCT-8 colon cancer cellsS J Vermeulen, P R Debruyne, G Marra, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Cardiovascular toxicities in cancer patients treated with immune checkpoint inhibitors: multicenter study using natural language processing on Belgian hospital dataD Delombaerde, C L Oeste, V Geldhof, et al.
Pageof 2